Life sciences · Journal article
World Journal of Pharmaceutical Research · September 16, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Physalis angulata L. (Solanaceae) is a medicinally important herb traditionally used for treating infections, inflammation, and metabolic disorders. The present study employed an integrated experimental and in silico approach to explore its phytochemical profile, nanoparticle synthesis potential, enzyme inhibitory activity, antimicrobial efficacy, and molecular mechanisms. Qualitative and quantitative phytochemical analyses of the methanolic leaf extract revealed the presence of diverse secondary metabolites including flavonoids, terpenoids, alkaloids, tannins, phenols, saponins, and glycosides, indicating a strong bioactive composition. The extract successfully mediated the green synthesis of copper nanoparticles (CuNPs), confirmed by UV–Visible spectroscopy (SPR peak at 273.7 nm), FTIR (functional groups of proteins and phenolics as reducing and capping agents), XRD (crystalline FCC copper structure, 25–30 nm), EDX (Cu 67.18 wt%), and SEM (spherical morphology, 104–124 nm). The synthesized CuNPs exhibited significant dose-dependent inhibitory activity against α-amylase, α-glucosidase, and pancreatic lipase, indicating